Tuesday, October 13, 2020

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.

from NYT > Health https://ift.tt/2GYTcCd
https://ift.tt/eA8V8J
on
Labels: ,

No comments:

Post a Comment

Thanks

Subscribe to: Post Comments (Atom)